Radioimmunoluminography: a tool for relating tissue antigen concentration to clinical outcome
1999

Measuring Protein Levels in Cancer Tissues

Sample size: 34 publication Evidence: high

Author Information

Author(s): Boxer G, Stuart-Smith S, Flynn A, Green A, Begent R

Primary Institution: Cancer Research Campaign Targeting and Imaging Group, Department of Oncology, Royal Free and University College Medical School

Hypothesis

Radioimmunoluminography (RILG) can provide a quantitative measurement of protein concentration in tissue sections.

Conclusion

RILG is a reliable method for quantifying carcinoembryonic antigen (CEA) levels in colorectal cancer tissues, which can help identify patients who may benefit from targeted therapies.

Supporting Evidence

  • RILG provided a linear correlation with known CEA concentrations.
  • IHC failed to show a similar correlation with CEA levels.
  • RILG showed a range of CEA concentrations in colorectal cancer tissues.

Takeaway

This study shows a new way to measure proteins in cancer tissues, which can help doctors decide the best treatment for patients.

Methodology

The study used radioimmunoluminography to measure CEA levels in tissue sections from colorectal cancer patients and compared it with traditional methods.

Participant Demographics

Colorectal cancer patients, with samples from both cryostat and paraffin sections.

Statistical Information

P-Value

P = 0.04 and P < 0.02

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690443

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication